Skip to main content Skip to main navigation menu Skip to site footer

An unusual case of primary hepatic neuroendocrine tumor: a case report

  • Titis Hadiyanti Setyadi ,
  • Putu Niken Ayu Amrita ,

Abstract

Introduction: Based on the results of medical imaging, primary hepatic neuroendocrine tumors (PHNETs) are an infrequent entity that is challenging to differentiate from other liver tumors. This case was taken to demonstrate the problem of diagnosis and management in a patient diagnosed with PHNET.

Case Presentation: We report an unusual case of a 41-year-old female with PHNET who initially had a chief complaint of an enlarged abdomen accompanied by a hard, solid lump in the upper right region. Complaints have been felt for the last four months and are getting bigger, accompanied by weight loss of more than 10 kg in the last three months. The patient was misdiagnosed with hepatocellular carcinoma based on an abdominal CT scan. Alpha-fetoprotein levels were within the normal limits. No serologic evidence of hepatitis B or C virus infection was found. A liver biopsy was performed with the result of PHNET.

Conclusion: It has been extremely difficult to diagnose this rare tumor, so we emphasize the significance of liver biopsy.

References

  1. DeLuzio MR, Barbieri AL, Israel G, Emre S. Two Cases of Primary Hepatic Neuroendocrine Tumors and a Review of the Current Literature. Ann Hepatol. 2017;16(4):621–9.
  2. Shah D, Mandot A, Cerejo C, Amarapurkar D, Pal A. The Outcome of Primary Hepatic Neuroendocrine Tumors: A Single-Center Experience. J Clin Exp Hepatol. 2019;9(6):710–5.
  3. Park CH, Chung JW, Jang SJ, Chung MJ, Bang S, Park SW, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. J Gastroenterol Hepatol. 2012;27(8):1306–11.
  4. Quartey. Primary Hepatic Neuroendocrine Tumor: What Do We Know Now? World J Oncol. 2011;
  5. Ishaq MR, Febriansyah NA, Soetojo S. A Rare Case of Neuroendocrine Tumor Following Radical Nephrectomy. Folia Medica Indonesiana. 2022;58(2):192–4.
  6. YALAV O, ULKU A, AKCAM TA, DEMIRYUREK H, DORAN F. Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses. The Turkish Journal of Gastroenterology. 2012;23(3):272–8.
  7. Kaya G, Pasche C, Osterheld M, Chaubert P, Fontolliet C. Primary neuroendocrine carcinoma of the liver: An autopsy case. Pathol Int. 2001;51(11):874–8.
  8. Ferolla P, Faggiano A, Mansueto G, Avenia N, Cantelmi MG, Giovenali P, et al. The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers. J Endocrinol Invest. 2008;31(3):277–86.
  9. Sippel RS, Chen H. Carcinoid Tumors. Surg Oncol Clin N Am. 2006;15(3):463–78.
  10. Putri DRI, Maimunah U, Retnowati E. SERUM AFP (ALPHA FETO PROTEIN) LEVELS PROFILE OF HEPATOCELLULAR CARCINOMA PATIENTS IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA. Majalah Biomorfologi. 2022;32(1):6.
  11. Hwang S, Lee Y-J, Lee S-G, Kim C-W, Kim K-H, Ahn C-S, et al. Surgical Treatment of Primary Neuroendocrine Tumors of the Liver. Journal of Gastrointestinal Surgery. 2008;12(4):725–30.
  12. Darmadi D, Ruslie RH, Pakpahan C. Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. Open Access Maced J Med Sci. 2021;9(B):797–800.
  13. Strosberg J. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol. 2010;16(24):2963.

How to Cite

Setyadi, T. H., & Amrita, P. N. A. (2023). An unusual case of primary hepatic neuroendocrine tumor: a case report. Bali Medical Journal, 13(1), 332–336. https://doi.org/10.15562/bmj.v13i1.4980

HTML
10

Total
6

Share

Search Panel

Titis Hadiyanti Setyadi
Google Scholar
Pubmed
BMJ Journal


Putu Niken Ayu Amrita
Google Scholar
Pubmed
BMJ Journal